Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2023 · 10-Q
Revenue$153.30M$153.30M+40.4% vs Q3 2022 Net Income-$8.54M-$8.54MN/M vs Q3 2022 EPS Diluted-$0.29-$0.29N/M vs Q3 2022 Gross Profit$128,920,000+44.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,638,000−66.9% Free Cash Flowderived-$3,350,000N/M Margins · derivedGross margin84.1%+2.2 pt vs Q3 2022
Operating margin-8.8%+7.0 pt vs Q3 2022
Net margin-5.6%+9.9 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 7, 2023 · 38 d after period end